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The ubiquitin–proteasome-systemThediscovery of the ubiquitin conjugationpathway and the identiﬁca-
tion of the 26S proteasome as the machine degrading polyubiquitinated
proteins opened a view into a completely new world of cellular
regulation. Proteolysis, previously considered as unspeciﬁc and thus less
important, suddenly evolved into a ﬁeld of pre-eminent importance. Cen-
tral cellular processes such as signal transduction, metabolic regulation,
cell cycle control, development, apoptosis, protein quality control, or anti-
gen presentation were found to depend on a functional ubiquitin–
proteasome-system. Defects in this system lead to severe diseases as for
instance inﬂammation, cancer or neurodegeneration. It is therefore of ut-
most importance to understand the players of the system, their function
and their molecular mechanism in the different cellular processes
comprehensively.
When in 2004 the ﬁrst review issue of Biochimica et Biophysica Acta
Molecular Cell Research on the ubiquitin–proteasome machinery
appeared, the ﬁeld had started to blossom.
Ten years later, improved and novel biochemical, cell biological and
structural approaches have led to a wealth of new insights into the sys-
tem. This has led to a signiﬁcantly deeper understanding of many cellular
processes and connected diseases. For example good structural knowl-
edge was only available of the 20S core particle, the proteolytically active
cylinder of the proteasome. However, recently the structural andmecha-
nistic features of the 19S regulatory particle and its cooperation with the
protease core begin to unravel. In addition, we begin to see that ubiquitin
is not a single “word” but the unit of a whole biological ‘language’. Key to
this complex ‘language’ is the type of modiﬁcation of a speciﬁc substrate
protein. It can vary between mono-ubiquitination, multiple
monoubiquitination andmodiﬁcation by ubiquitin chains. Since ubiquitin
chains are characterized by the lysine residues in ubiquitin used for the
ubiquitin–ubiquitin linkage, a variety of different chains can be used to
modify target molecules. Then, the dynamics of building, processing and
disassembly of ubiquitin chains is still far from being understood. The
number of substrate proteins and accordingly the number of cellular pro-
cesses these proteins are involved in, are steadily increasing. Additional
ubiquitin like proteins (UBL's) interconnecting with the ubiquitin lan-
guage diversify and reﬁne this modiﬁcation even more. Separate UBL
activation- and ligation systems operate and in certain cases UBL
(SUMO) and ubiquitin modiﬁcation is intertwined. Together with this
we learn about an increasing number of diseases which are connected
with the system.Wehave to learn about themistakes in the ubiquitin lan-
guage aswell as in the processing and degradationmachineries to be able
to understand the molecular basis of the diseases, and hopefully some
time from now will be able to ﬁnd drugs to combat them. The discovery
of the proteasome inhibitors bortezomib (Velcade®) and carﬁlzomib
(Kyprolis®) for treatment of multiple myeloma is a promising start.
The reviews in this volume will provide insights into our present
knowledge of the proteasome, its components, its assembly and its0167-4889/$ – see front matter © 2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.bbamcr.2013.09.009dynamics in the cell. Furthermore, the varying components of the
ubiquitin–proteasome system acting in different cellular processes as
well as the dynamics of ubiquitin linkage, assembly and disassembly
will be highlighted. Finally, diseases linked with defects in the system
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